QIAGEN Expands Clinical Decision Support for NGS in Oncology Labs
Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers
Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers
New test kit is immediately available, has AOAC PTM certification
World's largest medical trade fair starts in Dusseldorf in two weeks time
Current technological advances are broadening the diagnostic possibilities for lateral flow platforms
Clinical experts discuss a range of clinical, scientific and laboratory topics
New 3-part differential hematology analyzer delivers lower costs and wider range of use
Discover the latest clinical microbiology news, products and application notes
Siemens Healthcare Diagnostics introduced state-of-the-art hematology analyzers available to clinical laboratories
Research is helping identify biomarkers of Alzheimer’s Disease
Comparative study of tumor biopsy v noninvasive blood-based analyses published
Discover the latest clinical laboratory and point-of-care solutions from Siemens Healthcare Diagnostics
by John Collings, Global Product Manager, General Purpose Centrifuges at Thermo Fisher Scientific
KEYTRUDA is Merck's anti-PD-1 therapy for metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy
Researchers present data at breast cancer symposium showing MammaPrint/BluePrint can identify women who benefit from chemotherapy and targeted dual anti-HER2 drug treatment before surgery
Discover our latest clinical content
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies